Simultaneous effect of physical activity and anti-PDL1 injection on tumor weight and life span of mice with breast cancer

Abstract

Cancer is now the leading global cause of death, with breast cancer being particularly deadly for women. This study investigates how physical activity combined with anti-PD-L1 antibody administration affects tumor weight and lifespan in mice with breast cancer. In this study, 30 male and female BALB/c mice, averaging 17.76 grams in weight, were selected and divided into the following groups: PCG (n=6), EIC (n=6), EIE (n=6), EIA (n=6), and EIE+A (n=6). Following an acclimation period on the treadmill, mice underwent two initial 4-week training protocols, followed by a 2-week protocol after cancer induction. A one-way analysis of variance (ANOVA) was performed to analyze the research variables. Statistical analysis showed no significant changes in survival time or tumor weight in the PCG, EIC, and EIE groups of breast cancer mice. However, the EIA and EIE+A groups demonstrated significant improvements in both survival and tumor weight reduction (p<0.05). The findings of this study suggest that the combination of physical activity and anti-PDL-1 antibody administration may lead to tumor apoptosis by enhancing positive immunological effects, which could be effective for better cancer management. However, it is recommended that future studies investigate the immunological and physiological effects of the tumor microenvironment with the combination of physical activity and anti-PDL-1 antibody administration.

Keywords

• anti-pdl-1 antibody
• exercise oncology
• physical activity